ARTELO BIOSCIENCES, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ARTELO BIOSCIENCES, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($3.12M) | Nov 12, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($3.22M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($3.22M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($2.37M) | May 13, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($2.37M) | Nov 12, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($2.37M) | Aug 13, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($1.13M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($2.43M) | Aug 13, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($2.43M) | Nov 12, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($2.48M) | Nov 12, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($2.48M) | May 13, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($2.48M) | Aug 13, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($2.45M) | Nov 12, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($1.60M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.60M) | Aug 13, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($2.17M) | Aug 13, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($2.17M) | Nov 12, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($2.17M) | May 13, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($2.33M) | Nov 13, 2023 |
| Q3 | 2023 | Jun 30, 2022 | ($2.45M) | Nov 13, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($3.09M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($3.15M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($2.38M) | May 13, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($1.20M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($2.51M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($2.59M) | May 13, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($2.61M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.78M) | Aug 13, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($2.29M) | May 13, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($2.39M) | Nov 13, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($2.47M) | Aug 10, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($1.95M) | May 11, 2023 |
| Q1 | 2022 | Nov 30, 2021 | ($2.55M) | Jan 12, 2022 |
| Q3 | 2022 | Sep 30, 2021 | ($2.25M) | Nov 8, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($2.25M) | Aug 9, 2022 |
| Q3 | 2021 | May 31, 2021 | ($2.25M) | Jul 12, 2021 |
| Q1 | 2022 | Mar 31, 2021 | ($1.70M) | May 12, 2022 |
| Q2 | 2021 | Feb 28, 2021 | ($1.87M) | Apr 13, 2021 |
| Q1 | 2022 | Nov 30, 2020 | ($1.44M) | Jan 12, 2022 |
| Q3 | 2021 | May 31, 2020 | ($951.4K) | Jul 12, 2021 |